Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Seasonal Allergic Rhinitis In Pediatric Subjects

ClinicalTrials.gov ID: NCT00107757

Public ClinicalTrials.gov record NCT00107757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 50mcg and 100mcg for 2 Weeks in Pediatric Subjects Ages 2 to <12 Years With Seasonal Allergic Rhinitis (SAR)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.

Study identification

NCT ID
NCT00107757
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
576 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2005 (Type not available)
Primary completion
Not listed
Completion
Nov 2005 (Actual)
Last update posted
Sep 15, 2016

2005

United States locations

U.S. sites
65
U.S. states
26
U.S. cities
61
Facility City State ZIP Site status
GSK Investigational Site Scottsdale Arizona 85251 —
GSK Investigational Site Little Rock Arkansas 72202 —
GSK Investigational Site Costa Mesa California 92626 —
GSK Investigational Site Cudahy California 90201 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Long Beach California 90808 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Orange California 92868 —
GSK Investigational Site Riverside California 92506 —
GSK Investigational Site San Diego California 92123 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Centennial Colorado 80112 —
GSK Investigational Site Denver Colorado 80206 —
GSK Investigational Site Denver Colorado 80230 —
GSK Investigational Site Englewood Colorado 80112 —
GSK Investigational Site Fort Collins Colorado 80526 —
GSK Investigational Site Lakewood Colorado 80401 —
GSK Investigational Site Miami Florida 33176 —
GSK Investigational Site Tampa Florida 33613 —
GSK Investigational Site Gainesville Georgia 30501 —
GSK Investigational Site Lawrenceville Georgia 30045 —
GSK Investigational Site Lilburn Georgia 30047 —
GSK Investigational Site Stockbridge Georgia 30281 —
GSK Investigational Site Woodstock Georgia 30188 —
GSK Investigational Site Indianapolis Indiana 46208 —
GSK Investigational Site Topeka Kansas 66606 —
GSK Investigational Site Metairie Louisiana 70006 —
GSK Investigational Site Shreveport Louisiana 71105 —
GSK Investigational Site Baltimore Maryland 21236 —
GSK Investigational Site Bethesda Maryland 20814 —
GSK Investigational Site Brockton Massachusetts 02301 —
GSK Investigational Site North Andover Massachusetts 01845 —
GSK Investigational Site North Dartmouth Massachusetts 02747 —
GSK Investigational Site Springfield Massachusetts 01107 —
GSK Investigational Site Richland Michigan 49083 —
GSK Investigational Site Ypsilanti Michigan 48197 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Kansas City Missouri 64108 —
GSK Investigational Site Rolla Missouri 65401 —
GSK Investigational Site Warrensburg Missouri 64093 —
GSK Investigational Site Omaha Nebraska 68130 —
GSK Investigational Site Hackensack New Jersey 07601 —
GSK Investigational Site Ocean City New Jersey 07712 —
GSK Investigational Site Ithaca New York 14850 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site Utica New York 13502 —
GSK Investigational Site Durham North Carolina 27710 —
GSK Investigational Site Raleigh North Carolina 27607 —
GSK Investigational Site Canton Ohio 44718 —
GSK Investigational Site Cincinnati Ohio 45231 —
GSK Investigational Site Oklahoma City Oklahoma 73120 —
GSK Investigational Site Lake Oswego Oregon 97035 —
GSK Investigational Site Altoona Pennsylvania 16601 —
GSK Investigational Site Cranberry Township Pennsylvania 16066 —
GSK Investigational Site Pittsburgh Pennsylvania 15241 —
GSK Investigational Site Charleston South Carolina 29406 —
GSK Investigational Site Knoxville Tennessee 37922 —
GSK Investigational Site Nashville Tennessee 37203-1424 —
GSK Investigational Site Dallas Texas 75231 —
GSK Investigational Site Dallas Texas 75246 —
GSK Investigational Site El Paso Texas 79902 —
GSK Investigational Site El Paso Texas 79925 —
GSK Investigational Site Greenfield Wisconsin 53228 —
GSK Investigational Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00107757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 15, 2016 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00107757 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →